{
    "2021-03-16": [
        [
            {
                "time": "",
                "original_text": "医药生物行业周报：CXO、医疗服务、生物制品等板块预计Q1高增长",
                "features": {
                    "keywords": [
                        "医药生物",
                        "CXO",
                        "医疗服务",
                        "生物制品",
                        "Q1高增长"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药",
                        "生物制品"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "",
                "original_text": "疫苗板块抬升，万泰生物涨超5%、智飞生物收复失地",
                "features": {
                    "keywords": [
                        "疫苗",
                        "万泰生物",
                        "智飞生物",
                        "涨超5%"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药",
                        "疫苗"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2021-03-02",
                "original_text": "IPO周报-次新宝典：本批贝泰妮值得重点追踪(2021年3月第2周)",
                "features": {
                    "keywords": [
                        "IPO",
                        "贝泰妮",
                        "次新股"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药",
                        "化妆品"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "",
                "original_text": "业内：3月份建议重点关注业绩持续改善的医药个股",
                "features": {
                    "keywords": [
                        "医药",
                        "业绩持续改善",
                        "个股"
                    ],
                    "sentiment_score": 0.85,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            }
        ]
    ]
}